Cargando…

Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial

Ceftolozane/tazobactam, a cephalosporin-β-lactamase inhibitor combination, active against multidrug-resistant Gram-negative pathogens, is approved for treatment of adults with complicated urinary tract infections (cUTI). Safety and efficacy of ceftolozane/tazobactam in pediatric participants with cU...

Descripción completa

Detalles Bibliográficos
Autores principales: Roilides, Emmanuel, Ashouri, Negar, Bradley, John S., Johnson, Matthew G., Lonchar, Julia, Su, Feng-Hsiu, Huntington, Jennifer A., Popejoy, Myra W., Bensaci, Mekki, De Anda, Carisa, Rhee, Elizabeth G., Bruno, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990597/
https://www.ncbi.nlm.nih.gov/pubmed/36689671
http://dx.doi.org/10.1097/INF.0000000000003832